Global Regulatory Capacity


Applied Clinical Trials

Global Regulatory Capacity

Paul Pomerantz, Worldwide Executive Director of the Drug Information Association, discusses the issues taxing regulatory agencies worldwide as well as clinical trial complexity, lack of global harmonization, regulatory workload and more.

Related Content
© 2024 MJH Life Sciences

All rights reserved.